Literature DB >> 15089886

Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.

Ai Kubo1, Douglas A Corley.   

Abstract

OBJECTIVE: No prior studies have contrasted esophageal and gastric cardia carcinoma incidence rates among multiple ethnicities. We evaluated whether these adjacent cancers differ; such detailed demographic analyses would inform risk factor, screening, and intervention studies.
METHODS: We contrasted incidence rates and temporal trends from the Surveillance, Epidemiology, and End Results (SEER) cancer registry data between 1992 and 1998 for five groups: non-Hispanic whites (Caucasians), white Hispanics (Hispanics), blacks, Asians/Pacific Islanders (Asians/PI), and Native Americans (NA).
RESULTS: Caucasian males' esophageal adenocarcinoma rate (4.2 per 100,000 population/yr) was double that of Hispanics and four-fold higher than those of blacks, Asians/PI, and NA (p < 0.01). Female rates were much lower than male rates for all ethnicities. Similar to esophageal adenocarcinoma, cardia adenocarcinoma rates were highest in Caucasian males (3.4 per 100,000 population/yr); however, the ethnic differences were much less and female rates were comparable for all almost all ethnicities (range 0.6-0.7 per 100,000 population/yr) except NA. Esophageal adenocarcinoma incidence rates increased significantly only in Caucasians (males 5.6%/yr, females 9%/yr; p < 0.05) and cardia cancer rates did not increase for any ethnicity during this period. In contrast, esophageal squamous cell carcinoma incidence rates were highest in blacks (8.8 per 100,000 population/yr) and Asians/PI (3.9 per 100,000 population/yr) and rates were stable or declined for all ethnicities between 1992 and 1998.
CONCLUSIONS: Esophageal and cardia carcinoma incidence rates vary much more markedly by ethnicity and gender than previously reported and the two sites differ from each other. Current putative risk factors do not adequately explain these large differences. These data have implications for risk factor, screening, and intervention studies.

Entities:  

Mesh:

Year:  2004        PMID: 15089886     DOI: 10.1111/j.1572-0241.2004.04131.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  57 in total

1.  Geographic difference in advanced gastric cancer prevalence and chemotherapy treatment results: could it really be an independent prognostic factor?

Authors:  Junichi Sakamoto; Koji Oba
Journal:  Gastric Cancer       Date:  2012-07       Impact factor: 7.370

Review 2.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 3.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

4.  Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors:  Douglas A Corley
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

5.  Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.

Authors:  Linda C Cummings; Gregory S Cooper
Journal:  Cancer Detect Prev       Date:  2008-04-10

6.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

7.  Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis.

Authors:  Nooman Gilani; Richard-D Gerkin; Francisco-C Ramirez; Shahina Hakim; Adam-C Randolph
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

8.  Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Laurel Habel; Wei Zhao; Patricia Leighton; Gregory Rumore; Charles Quesenberry; Patricia Buffler; Gladys Block
Journal:  Am J Gastroenterol       Date:  2008-10-01       Impact factor: 10.864

Review 9.  Esophageal cancer: The latest on chemoprevention and state of the art therapies.

Authors:  Gregoire F Le Bras; Muhammad H Farooq; Gary W Falk; Claudia D Andl
Journal:  Pharmacol Res       Date:  2016-08-24       Impact factor: 7.658

10.  Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study.

Authors:  Sarah J Crane; G Richard Locke; William S Harmsen; Alan R Zinsmeister; Yvonne Romero; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.